Elimination of pelvic exams in a high-risk ovarian cancer screening program.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e13059-e13059 ◽  
Author(s):  
Kisha T Hope ◽  
Anna Everett Strohl ◽  
Patricia Smyrniotis ◽  
Jeffrey Dungan ◽  
Shohreh Shahabi ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Screening ◽  
High Risk ◽  
Screening Program ◽  
Ovarian Cancer Screening ◽  
Cancer Screening Program

scholarly journals Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States

JAMA Oncology ◽  
2018 ◽  
Vol 4 (2) ◽  
pp. 190 ◽  
Author(s):  
Haley A. Moss ◽  
Andrew Berchuck ◽  
Megan L. Neely ◽  
Evan R. Myers ◽  
Laura J. Havrilesky
Keyword(s):  
United States ◽  
Ovarian Cancer ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Screening Program ◽  
The United States ◽  
Ovarian Cancer Screening ◽  
Cancer Screening Program

scholarly journals Factors associated with return for routine annual screening in an ovarian cancer screening program

2007 ◽  
Vol 104 (3) ◽  
pp. 695-701 ◽  
Author(s):  
Michael A. Andrykowski ◽  
Mei Zhang ◽  
Edward J. Pavlik ◽  
Richard J. Kryscio
Keyword(s):  
Ovarian Cancer ◽  
Cancer Screening ◽  
Screening Program ◽  
Ovarian Cancer Screening ◽  
Factors Associated ◽  
Cancer Screening Program ◽  
Annual Screening

European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population

2017 ◽  
pp. 124-127
Author(s):  
Marian J. Mourits ◽  
G. H. de Bock
Keyword(s):  
United States ◽  
Ovarian Cancer ◽  
Cancer Screening ◽  
High Risk ◽  
The United States ◽  
High Risk Population ◽  
Genome Wide Association Studies ◽  
Hereditary Ovarian Cancer ◽  
Ovarian Cancer Screening ◽  
Screening And Prevention

The history of screening and prevention of ovarian cancer among high-risk women in the United States and Europe is one of mutual inspiration, with researchers learning from each others’ findings and insights and collaborating with investigators from both sides of the Atlantic ocean. Examples of simultaneous and joint development of knowledge and scientific points of view include the paradigm shift from ovarian to fallopian tube high-grade serous cancer and the cessation of simultaneous adoption of ovarian cancer screening by clinicians in both the United States and Europe. Examples of joint efforts with fruitful results include international collaboration in large population-based, genome-wide association studies and in epidemiologic database studies. Research in the field of hereditary ovarian cancer is a great example of mutual inspiration and joint efforts for the purpose of improving knowledge and health care for women with hereditary ovarian cancer.

Sign in / Sign up

Export Citation Format

Share Document